Literature DB >> 29508158

What Is the Role of Left Atrial Appendage Closure in the Rhythm Control of Atrial Fibrillation?

Albert C Lin1, Bradley P Knight2.   

Abstract

Interventional catheter ablation approaches to the rhythm control of atrial fibrillation (AF) have advanced significantly in the past decade. The foundation of the catheter ablation in AF is electrical isolation of the pulmonary veins (PVI). However, PVI only in more advanced stages of AF (persistent AF) has only modest to poor success rates prompting a search for alternative and adjunctive procedures to improve the outcomes of ablation in persistent AF. The left atrial appendage (LAA) is well understood to be a primary source of emboli in AF but less well known be a trigger or driver for AF. Therefore, LAA exclusion is an attractive target to potentially improve AF ablation outcomes in more advanced stages of AF and possibly as an alternative to chronic oral anticoagulation in the prevention of stroke and systemic embolism in AF. However, the precise role of LAA closure in the interventional approach to AF is still to be elucidated with ongoing clinical investigations.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Stroke; Systemic embolism

Year:  2018        PMID: 29508158     DOI: 10.1007/s11936-018-0620-4

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  22 in total

1.  Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage.

Authors:  Christoph T Starck; Jan Steffel; Maximilian Y Emmert; Andre Plass; Srijoy Mahapatra; Volkmar Falk; Sacha P Salzberg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-30

2.  Conversion of persistent atrial fibrillation to sinus rhythm after LAA ligation with the LARIAT device.

Authors:  Nitish Badhwar; Suneet Mittal; Abdi Rasekh; Smit Vasaiwala; Dan Musat; Payam S Naeini; Qi Fang; Karin Nentwich; Thomas Deneke; Jie Chang; Dhanunjaya Lakkireddy; David Wilber; Randall J Lee
Journal:  Int J Cardiol       Date:  2016-09-28       Impact factor: 4.164

Review 3.  Embryology and Anatomy of the Left Atrial Appendage: Why Does Thrombus Form?

Authors:  Arun Kanmanthareddy; Yeruva Madhu Reddy; Ajay Vallakati; Matthew B Earnest; Jayant Nath; Ryan Ferrell; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  Interv Cardiol Clin       Date:  2014-01-22

4.  Anatomic analysis of the left atrial appendage after closure with the LARIAT device.

Authors:  Krzysztof Bartus; Remo L Morelli; Wojciech Szczepanski; Boguslaw Kapelak; Jerzy Sadowski; Randall J Lee
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08

5.  Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation.

Authors:  C Hwang; T J Wu; R N Doshi; C T Peter; P S Chen
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

6.  Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation.

Authors:  Mélèze Hocini; Ashok J Shah; Isabelle Nault; Prashanthan Sanders; Matthew Wright; Sanjiv M Narayan; Yoshihide Takahashi; Pierre Jaïs; Seiichiro Matsuo; Sébastien Knecht; Frédéric Sacher; Kang-Teng Lim; Jacques Clémenty; Michel Haïssaguerre
Journal:  Heart Rhythm       Date:  2011-07-12       Impact factor: 6.343

7.  Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation.

Authors:  Dhanunjaya Lakkireddy; Muhammad R Afzal; Randall J Lee; Hosakote Nagaraj; David Tschopp; Brett Gidney; Christopher Ellis; Eric Altman; Brian Lee; Saibal Kar; Nitish Bhadwar; Mauricio Sanchez; Varuna Gadiyaram; Rudolph Evonich; Abdi Rasekh; Jie Cheng; Frank Cuoco; Sheetal Chandhok; Sampath Gunda; Madhu Reddy; Donita Atkins; Sudharani Bommana; Phillip Cuculich; Douglas Gibson; Jayant Nath; Ryan Ferrell; Earnest Matthew; David Wilber
Journal:  Heart Rhythm       Date:  2016-02-09       Impact factor: 6.343

8.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

9.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

10.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.